0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Negative revenue growth while 0425.HK stands at 16.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.81%
Negative gross profit growth while 0425.HK is at 16.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
0.61%
EBIT growth below 50% of 0425.HK's 4.65%. Michael Burry would suspect deeper competitive or cost structure issues.
0.61%
Operating income growth under 50% of 0425.HK's 4.65%. Michael Burry would be concerned about deeper cost or sales issues.
27.53%
Positive net income growth while 0425.HK is negative. John Neff might see a big relative performance advantage.
-44.39%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
3.34%
Positive diluted EPS growth while 0425.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
129.62%
Share count expansion well above 0425.HK's 0.69%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.43%
Diluted share count expanding well above 0425.HK's 0.61%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
114.48%
OCF growth above 1.5x 0425.HK's 46.55%. David Dodd would confirm a clear edge in underlying cash generation.
79.98%
FCF growth 50-75% of 0425.HK's 140.74%. Martin Whitman would see if structural disadvantages exist in generating free cash.
31.83%
10Y revenue/share CAGR under 50% of 0425.HK's 568.94%. Michael Burry would suspect a lasting competitive disadvantage.
-55.08%
Negative 5Y CAGR while 0425.HK stands at 163.78%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-50.53%
Negative 3Y CAGR while 0425.HK stands at 65.69%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
305.97%
10Y OCF/share CAGR at 50-75% of 0425.HK's 539.41%. Martin Whitman might fear a structural deficiency in operational efficiency.
-9.31%
Negative 5Y OCF/share CAGR while 0425.HK is at 245.72%. Joel Greenblatt would question the firm’s operational model or cost structure.
-66.91%
Negative 3Y OCF/share CAGR while 0425.HK stands at 72.30%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-34.65%
Negative 10Y net income/share CAGR while 0425.HK is at 309.20%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-33.96%
Negative 5Y net income/share CAGR while 0425.HK is 130.84%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
110.85%
3Y net income/share CAGR above 1.5x 0425.HK's 67.44%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Negative 5Y equity/share growth while 0425.HK is at 66.90%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-32.09%
Negative 3Y equity/share growth while 0425.HK is at 39.81%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Firm’s AR is declining while 0425.HK shows 13.65%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
83.57%
Inventory growth well above 0425.HK's 19.64%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-17.48%
Negative asset growth while 0425.HK invests at 10.92%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
We have a declining book value while 0425.HK shows 7.75%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.12%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-18.82%
Our R&D shrinks while 0425.HK invests at 18.87%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
We cut SG&A while 0425.HK invests at 36.56%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.